Active Stocks
Tue Jul 14 2026 15:46:11
  1. Kotak Mahindra Bank share price
  2. 378.80 -1.53%
  1. Bajaj Finance share price
  2. 1,007.40 -1.52%
  1. Tata Steel share price
  2. 188.35 0.64%
  1. ITC share price
  2. 275.55 -1.48%
  1. HDFC Bank share price
  2. 809.10 -1.16%
Business News > Mint Authors > T. Surendar

T. Surendar

Consulting editor

T. Surendar is a senior journalist at Mint with nearly three decades of experience covering business, markets, and corporate India. Since beginning his career in 1996, he has built a reputation for insight-driven reporting on corporate strategy, with a particular focus on India’s large, family-owned businesses and their evolution.

At Mint, he writes on corporate strategy, market trends, and regulatory developments, bringing depth and clarity to complex business stories. Over the years, he has worked with leading publications including India Today and Businessworld, and was part of the founding editorial teams of Forbes India and Fortune India. Most recently, he served as managing editor at The Morning Context, where he led long-form and investigative journalism.

Earlier in his career, Surendar served as national business features editor at The Times of India, India’s largest-circulated English daily, where he broke several important stories, including the one on the Apollo Hospitals chain losing out on their Sri Lankan venture and the guar gum trading scam.

Prior to his journalism career, Surendar worked across the pharmaceutical, industrial automation, and diamond jewellery sectors, and also as an equity analyst—experience that informs his nuanced understanding of corporate strategy and markets.

Surendar is known for breaking trend-defining stories and producing authoritative explainers on key corporate developments, including succession planning at Reliance Industries. He has interviewed some of India’s most influential business leaders, including Mukesh Ambani, Ratan Tata, Kumar Mangalam Birla, Anand Mahindra, and Dilip Shanghvi.

A Chevening Scholar in Journalism, he completed a specialised programme at the University of Westminster, and has also undergone a Newsroom Leadership Program conducted by Columbia University. He holds a bachelor’s degree in mathematics and has taught journalism courses at the University of Mumbai.

He has moderated and conducted high-profile discussions at forums such as Fortune India’s Most Powerful Women event. His work is defined by rigour, independence, and a commitment to helping readers understand the strategic forces shaping corporate India.

ARTICLES BY T. SURENDAR

Beyond generics: Glenmark plans a bold 10-year pivot to global drug innovation

5 min read . 07 Jul 2026

India extends deadline for rare earth magnet incentive scheme by a month

2 min read . 26 Jun 2026

Vedanta's Navin Agarwal bets big on rare earth magnets, sets up firm eyeing PLI

2 min read . 26 Jun 2026

Why India’s corporate titans are resisting a ₹7,280-cr magnet race

13 min read . 25 Jun 2026

At 100, the Bajaj Group is writing a new chapter—on healthcare

9 min read . 20 May 2026

Son rise at Sun: Decoding the architecture of Dilip Shanghvi’s global empire

1 min read . 06 May 2026

Succession buzz lifts Biocon shares, but Kiran Mazumdar-Shaw says 'not imminent'

3 min read . 05 May 2026

Sun Pharma mega deal for Organon signals fading US generics allure

5 min read . 28 Apr 2026

The unexpected second purpose of Gujarat's financial hub

9 min read . 13 Apr 2026

Inside the unprecedented silence of Morbi

11 min read . 22 Mar 2026

Private capex revival around the corner: Sunil Mathur, Siemens Ltd

5 min read . 13 Mar 2026

Aurobindo Pharma takes a penicillin shot

9 min read . 25 Feb 2026

UPL restructures but debt clouds the reset; stock tumbles 14%

4 min read . 23 Feb 2026

Why Thyrocare's Velumani is eyeing India’s dental market

8 min read . 11 Feb 2026

What Dilip Shanghvi, Yusuf Hamied, Vinita Gupta think of Indian Pharma's future

5 min read . 10 Feb 2026

Longer tax holiday, lower post-holiday tax: How IFSC units benefit

3 min read . 01 Feb 2026

Inside India’s big sports power shift

10 min read . 26 Jan 2026

Why Sun Pharma’s hefty bid for Organon has divided investors

4 min read . 21 Jan 2026

Ajanta Pharma targets emerging markets for weight loss drug with Biocon tie-up

3 min read . 23 Dec 2025

World's deepest marathon: An Indian CEO's first in a Swedish mine

5 min read . 20 Dec 2025
Recommended For You